Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Structure Therapeutics Inc. - American Depositary Shares (NQ: GPCR )

60.73 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 60.73
Bid (Size) 56.69 (1)
Ask (Size) 77.00 (2)
Prev. Close 60.73
Today's Range 60.73 - 60.73
52wk Range 20.80 - 75.02
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
If You Can Only Buy One Biotech Stock in December, It Better Be One of These 3 Names
As we head into December 2023, some of the hottest investment opportunities can be found in these biotech stocks. 
Via InvestorPlace
2 Biotech Stocks That Could Soar in December
These two biotechs have important catalysts coming up in December. 
Via The Motley Fool

Performance

YTD
+133.58%
+133.58%
1 Month
-11.37%
-11.37%
3 Month
+114.06%
+114.06%
6 Month
+96.28%
+96.28%
1 Year
+133.58%
+133.58%

More News

Read More
What 6 Analyst Ratings Have To Say About Structure Therapeutics
Via Benzinga
Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
From Structure Therapeutics Inc.
Via GlobeNewswire
Should You Still Buy the Nasdaq's Best-Performing October Stocks?
Via The Motley Fool
4 Analysts Have This to Say About Structure Therapeutics
Via Benzinga
Top 5 Health Care Stocks That Should Keep You Up At Night
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2023
Via Benzinga
Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders
Via FinancialNewsMedia
BMO Capital Maintains Outperform Rating for Structure Therapeutics: Here's What You Need To Know
Via Benzinga
Why Shares of Structure Therapeutics Are Up Monday
Via The Motley Fool
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Shares of Structure Therapeutics Are Soaring on Friday
Via The Motley Fool
Nasdaq Gains Over 1%; Nike Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Newcomer Structure Throws Down The Gauntlet In Obesity Treatment -- Shares Soar 66%
Via Investor's Business Daily
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Is Obesity Focused Structure Therapeutics Stock Trading Higher Today?
Via Benzinga
Structure Therapeutics Announces $300 Million Private Placement Equity Financing
From Structure Therapeutics Inc.
Via GlobeNewswire
Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
From Structure Therapeutics Inc.
Via GlobeNewswire
Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights
From Structure Therapeutics Inc.
Via GlobeNewswire
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors
From Structure Therapeutics Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.